Immunoadsorption and Plasma Exchange are Comparable in Anti-Neutrophil Cytoplasmic Antibodies or Anti-Glomerular Basement Membrane Removal Kinetics.
免疫吸附與血漿交換在抗中性粒細胞胞漿抗體或抗腎小球基底膜去除動力學上具有可比性。
Kidney Int Rep 2024-09-18
Pericatheter Leak Associated With Earlier Peritoneal Dialysis Initiation Does Not Influence Long-Term Outcomes.
早期開始腹膜透析相關的導管周圍漏液不影響長期結果。
Kidney Int Rep 2024-09-18
Gene Expression Sets and Renal Profiling from the Renal AL Amyloid Involvement and NEOD00 (RAIN) Trial.
來自腎臟 AL 淋巴瘤參與及 NEOD00 (RAIN) 試驗的基因表達集和腎臟剖析。
Kidney Int Rep 2024-09-18
Validation of a Clinical Scale for Early Detection of Infections at the Exit Site of Central Venous Catheters for Hemodialysis.
中央靜脈導管出口部位感染早期檢測臨床量表的驗證。
Kidney Int Rep 2024-09-18
Prevalence of Mendelian Kidney Disease Among Patients With High-Risk <i>APOL1</i> Genotypes Undergoing Commercial Genetic Testing in the United States.
美國高風險 <i>APOL1</i> 基因型患者接受商業基因檢測的孟德爾腎病流行率。
Kidney Int Rep 2024-09-18
Importance of <i>IFT140</i> in Patients with Polycystic Kidney Disease Without a Family History.
無家族史的多囊腎病患者中<i>IFT140</i>的重要性。
Kidney Int Rep 2024-09-18
APOL1 High-Risk Genotype is Not Associated With New or Worsening of Proteinuria or Kidney Function Decline Following COVID-19 Vaccination.
APOL1 高風險基因型與 COVID-19 疫苗接種後新發或惡化的蛋白尿或腎功能下降無關。
Kidney Int Rep 2024-09-18
Design and Rationale of the Phase 2 Baricitinib Study in Apolipoprotein L1-Mediated Kidney Disease (JUSTICE).
Apolipoprotein L1 介導的腎病 (JUSTICE) 第二期 Baricitinib 研究的設計與原理。
Kidney Int Rep 2024-09-18